- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.03. | Agilon Health CTO acquires shares, withholds some for tax obligations | 3 | Investing.com | ||
| 19.03. | Agilon Health exec buys shares, totaling $0 in transactions | 2 | Investing.com | ||
| 19.03. | Agilon Health executive acquires shares, withholds some for taxes | 1 | Investing.com | ||
| 19.03. | Agilon Health executive acquires shares, withholds for taxes | 1 | Investing.com | ||
| 19.03. | Agilon Health CFO purchases shares, withholds some for tax obligations | 1 | Investing.com | ||
| 11.03. | JPMorgan says agilon health must 'rebuild investor confidence', cuts stock PT | 6 | Investing.com | ||
| 08.03. | Earnings call: Agilon health lowers 2024 outlook amid transition challenges | 1 | Investing.com | ||
| 28.02. | agilon health, inc. (AGL) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 28.02. | agilon health inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 27.02. | agilon health inc. Q4 Earnings Summary | 1 | RTTNews | ||
| 27.02. | agilon health, inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 27.02. | agilon health GAAP EPS of -$0.41 misses by $0.12, revenue of $1.06B beats by $40M | 2 | Seeking Alpha | ||
| 27.02. | Agilon Health: Q4 Earnings Insights | 1 | Benzinga.com | ||
| 27.02. | agilon health Reports Fourth Quarter 2023 Results | 135 | Business Wire | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
| 26.02. | Agilon health stock downgraded at TD Cowen, price target halved to $6.50 | 3 | Investing.com | ||
| 26.02. | Jefferies slashes Agilon Health stock, shares investor skepticism | 2 | Investing.com | ||
| 22.02. | Analyst Expectations For Agilon Health's Future | 2 | Benzinga.com | ||
| 09.02. | agilon health announces CMO transition, initiates search | 1 | Investing.com | ||
| 08.02. | agilon health says Benjamin Kornitzer to transition from role as CMO | 2 | Seeking Alpha | ||
| 08.02. | agilon health, inc. - 8-K, Current Report | - | SEC Filings |
Seite:
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 12,306 | +0,67 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| NANO-X IMAGING | 8,600 | -5,18 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| BUTTERFLY NETWORK | 0,751 | -8,72 % | Butterfly Network expands maternal ultrasound efforts across Africa | ||
| GOODRX | 6,690 | -0,59 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,200 | +2,35 % | The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results | ||
| CARMAT | 3,830 | +0,79 % | CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024 | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| HYPERFINE | 0,830 | +2,47 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 32,700 | +2,57 % | Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care | ||
| MIMEDX | 6,290 | +2,11 % | MiMedx Group, Inc: MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30 | ||
| BIOMERICA | 0,730 | -1,36 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| ATRION | 362,00 | -2,69 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| ATRICURE | 23,200 | -0,81 % | AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management | ||
| CASTLE BIOSCIENCES | 19,250 | +0,26 % | Castle Biosciences Inc.: Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | If choosing to use a molecular test to rule-out a sentinel lymph node biopsy (SLNB) in patients diagnosed with melanoma, it is important to show that patients foregoing an SLNB have low risk outcomes... ► Artikel lesen | |
| AMWELL | 0,546 | +5,18 % | Amwell® to Report First Quarter 2024 Operating Results May 1 | ||
| TALKSPACE | 3,140 | +5,72 % | Talkspace to Report First Quarter 2024 and Host Conference Call |
AGILON HEALTH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,065 (+1,21 %) liegt der Kurs bei 5,450 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
